vcvibes

Arboretum Ventures, LLC

SEC exempt reporting adviser (venture capital exemption).

HQ
MI

Arboretum Ventures, LLC is a venture firm with a team of managing partners, venture partners, a principal, and associates. Its portfolio spans healthcare and life sciences companies, including medical devices, diagnostics tools, pharmaceuticals, and healthcare data analytics. The firm has invested in Endogenex and Motif Neurotech, and promoted Jeff Terrell to Managing Partner.

New fund likely raising soon

The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.

01 · Says / Does

TagSaysDoesHistorically (to 2020)
StagesNot statedNot enough dated dealsSeries B, Growth, Series A
SectorsNot statedNot enough dated dealsHealthtech, Biotech, Medical devices, Manufacturing
RegionsNot statedNot enough dated dealsMI, CA

Says: what the firm's funds state. Does: from 2 dated deals in the last 24 months.

Historical focus (through 2020), derived from historical deal data.

YearDealsTop sectors
20033Healthtech, Biotech, Life sciences and research tools
20051Healthtech, Manufacturing
20064Healthtech, Biotech, Devtools
20075Healthtech, Manufacturing, Medical devices
20085Biotech, Healthtech, Medical devices
20093Biotech, Healthtech, Medical devices
20104Biotech, Healthtech, Medical devices
20116Healthtech, Biotech, Medical devices
20126Healthtech, Medical devices, Biotech
20138Healthtech, Biotech, Medical devices
20144Healthtech, Medical devices, Biotech
20153Biotech, Healthtech, Medical devices
20166Healthtech, Biotech, Medical devices
20173Biotech, Healthtech, Medical devices
20186Healthtech, Biotech, Digital health
20193Digital health, Healthtech, Biotech
20202Healthtech, Biotech

Stage mix over time

2010 Series A: 12010 Series B: 22010 Growth: 1102011 Series A: 22011 Series B: 22011 Growth: 1112012 Series A: 12012 Series B: 12012 Growth: 3122013 Series A: 12013 Series B: 32013 Growth: 2132014 Series B: 12014 Growth: 1142015 Growth: 1152016 Series A: 22016 Series B: 2162017 Series B: 22017 Growth: 1172018 Series A: 22018 Series B: 3182019 Seed: 12019 Series A: 12019 Growth: 1192020 Series A: 12020 Series B: 120212223242526
  • Pre-seed
  • Seed
  • Series A
  • Series B
  • Growth
Share of rounds by stage, per year. Striped years have fewer than 3 rounds.Historical focus (through 2020), derived from historical deal data.
Rounds by stage and year
YearPre-seedSeedSeries ASeries BGrowth
201000121
201100221
201200113
201300132
201400011
201500001
201600220
201700021
201800230
201901101
202000110
202100000
202200000
202300000
202400000
202500000
202600000

02 · Fund history

FundYearSizeStatus
Arboretum Ventures VI, L.P.

Healthcare venture capital firm investing in early-stage startups focused on medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies, seeking innovations that improve patient outcomes and reduce healthcare costs. Inferred from the firm's website

approx. 2022$250M to $260.43M (Form D and SEC adviser filing)Late investment period

03 · People across funds

04 · Recent deals

  • Apr 1, 2026Motif NeurotechStage unknownFirmsource
  • Mar 1, 2026EndogenexStage unknownFirmsource

05 · Latest from the firm

06 · Sources

  1. HTTPS://WWW.ARBORETUMVC.COM
  2. https://www.arboretumvc.com/team/
  3. https://www.arboretumvc.com/portfolio/
  4. https://www.arboretumvc.com/2026/03/
  5. https://www.arboretumvc.com/2026/04/
  6. https://www.arboretumvc.com/2026/05/

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026